Redx Pharma to open new R&D center in UK
The new venture, Redx Anti-Infectives, will create 119 high value science jobs at the site, establishing a new team to develop drugs combatting resistance to antibiotics and new
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibbâs (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.